Carl KestensOct 21, 202212 min readThe $10 billion dollar unicorn in INmune Bio: on fast-progressors in AD, APOE4, TREM2 and EMACCSummary APOE4, involved in different mechanisms in the brain including lipid homeostasis, is the strongest risk factor for Alzheimer’s...
Carl KestensSep 23, 202212 min readThe $10 Billion unicorn in INmune Bio: the potential of XPro in Parkinson’sSummary The evolution of the treatment failures for Parkinson’s disease has striking similarities with Alzheimer’s. Just like in...
Carl KestensSep 2, 20228 min readThe FDA’s two leaps at once: on fast approval pathways and neurofilament lightSummary Neurofilament Light (NfL) is potentially the most important biomarker in neurodegenerative diseases. The FDA’s AdCom validated...
Carl KestensJul 30, 20229 min readThe $10 billion unicorn in INMB: on allostatic load, and why all the others may have non-respondersSummary Allostatic load is the cumulative burden of stressors one encounters throughout life. The underlying causes/triggers for any...